Emergent Biosolutions Inc (EBS)
Financing Cash Flow
-$24.40M
Quarterly · Period ending: · USD
EBS Financing Cash Flow
Latest reported-$24.40Mperiod ending
Latest reported-$24.40Mperiod ending
EBS Quarterly Cash from Financing ($61.64M → -$24.40M)
Quarterly financing cash flow
High-resolution chart · PNG
EBS financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -24,400,000 | |
| -11,400,000 | |
| -113,900,000 | |
| -15,900,000 | |
| -6,400,000 | |
| -400,000 | |
| 500,000 | |
| -180,300,000 | |
| -50,900,000 | |
| 40,700,000 | |
| 4,700,000 | |
| -43,000,000 | |
| -486,900,000 | |
| -10,500,000 | |
| 353,100,000 | |
| 229,300,000 | |
| -30,700,000 | |
| -70,500,000 | |
| -110,000,000 | |
| -5,000,000 | |
| -3,800,000 | |
| -22,200,000 | |
| -2,300,000 | |
| 87,100,000 | |
| 4,700,000 | |
| -20,000,000 | |
| -57,900,000 | |
| -19,700,000 | |
| 100,100,000 | |
| -58,400,000 | |
| 785,980,000 | |
| 1,677,000 | |
| 3,168,000 | |
| -2,125,000 | |
| -34,146,000 | |
| 4,687,000 | |
| 765,000 | |
| -22,707,000 | |
| 1,779,000 | |
| -44,415,000 | |
| 15,366,000 | |
| 8,629,000 | |
| 12,972,000 | |
| 3,076,000 | |
| 6,405,000 | |
| 10,996,000 | |
| 3,689,000 | |
| 402,000 | |
| 1,909,000 | |
| 192,874,000 | |
| 7,510,000 | |
| 647,000 | |
| -540,000 | |
| 995,000 | |
| -1,350,000 | |
| -784,000 | |
| 1,099,000 | |
| -730,000 | |
| -2,454,000 | |
| 14,347,000 | |
| -1,037,000 | |
| 3,395,000 | |
| 2,963,000 | |
| 807,000 | |
| -14,002,000 | |
| 874,000 | |
| 26,692,000 | |
| -11,870,000 | |
| -166,000 | |
| 188,000 | |
| 2,892,000 | |
| 4,484,000 | |
| -700,000 | |
| 2,292,000 | |
| 5,107,000 | |
| 14,411,000 | |
| 5,872,000 | |
| -6,899,000 | |
| 61,635,000 |